Pfizer
-
Markets
Pfizer Boosts COVID Vaccine Sales Forecast by $2 billion
Pfizer Inc (PFE.N) on Tuesday raised its forecast for annual sales of its COVID-19 vaccine by $2 billion to $34…
Read More »
Pfizer Inc (PFE.N) on Tuesday raised its forecast for annual sales of its COVID-19 vaccine by $2 billion to $34…
Read More »The United States on Wednesday authorized Pfizer Inc’s (PFE.N) antiviral COVID-19 pill for people ages 12 and older at risk…
Read More »A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received…
Read More »